Howard Trachtman, MD - Pioneering Progress In Focal Segmental Glomerulosclerosis: Time is Ticking To Save The Nephron

Visit https://www.peervoice.com/BVP860 to view the entire programme with slides. After completing “Howard Trachtman, MD - Pioneering Progress In Focal Segmental Glomerulosclerosis: Time is Ticking To Save The Nephron”, participants will be able to: Identify the current challenges in the diagnosis and management of focal segmental glomerulosclerosis (FSGS); Recognise genetic and socio-environmental factors that contribute to the disproportionate burden of FSGS and end stage kidney disease in Black communities; Describe the pathophysiology of FSGS, including the role of endothelin-1 and angiotensin II in glomerular injury; and Appraise recent data from trials examining the safety and efficacy of emerging therapies in FSGS.